Recognising the need for a national approach for the recommended best practice for
the follow-up of implanted cardiac rhythm devices to ensure patient safety, this document
has been produced by the Cardiac Society of Australia and New Zealand (CSANZ). It
draws on accepted practice standards and guidelines of international electrophysiology
bodies. It lays out methodology, frequency, and content of follow-up, including remote
monitoring; personnel, including physician, allied health, nursing and industry; paediatric
and adult congenital heart patients; and special considerations including magnetic
resonance imaging scanning, perioperative management, and hazard alerts.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart, Lung and CirculationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association.Europace. 2008; 10: 707-725
- 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: developed by the Task Force on Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA).Eur Heart J. 2021; 42: 3427-3520
- 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.Europace. 2019; 21: 1442-1443
- Position statement on the management of cardiac electrophysiology and cardiac implantable electronic devices in Australia during the COVID-19 pandemic: a living document.Heart Lung Circ. 2020; 29: e57-e68
- HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices.Heart Rhythm. 2015; 12: e69-e100
- Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Use of Remote Monitoring for Cardiovascular Implantable Electronic Device Follow-up.Can J Cardiol. 2013; 29: 644-651
- Remote monitoring of cardiac implanted electronic devices: legal requirements and ethical principles - ESC Regulatory Affairs Committee/EHRA joint task force report.Europace. 2020; 22: 1742-1758
- ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).Europace. 2012; 14: 278-293
- 2017 ACC/HRS lifelong learning statement for clinical cardiac electrophysiology specialists.J Am Collf Cardiol. 2018; 71: 231-250
- 2015 ACC/AHA/HRS advanced training statement on clinical cardiac electrophysiology (a revision of the ACC/AHA 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion).Circ Arrhythm Electrophysiol. 2015; 8: 1522-1551
- COCATS 4 Task Force 11: training in arrhythmia diagnosis and management, cardiac pacing, and electrophysiology.J Am Coll Cardiol. 2015; 65: 1854-1865
- 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices.Heart Rhythm. 2017; 14: e97-e153
- Canadian Cardiovascular Society/Canadian Anesthesiologists’ Society/Canadian Heart Rhythm Society joint position statement on the perioperative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices.Can J Cardiol. 2012; 28: 141-151
- The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management: this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS).Heart Rhythm. 2011; 8: 1114-1154
- British Heart Rhythm Society Guidelines for the management of patients with cardiac implantable electronic devices (CIEDs) around the time of surgery.British Heart Rhythm Society, 2021
- 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm. 2017; 14: e503-e551
Shah, MJ, Silka MJ, Silva JNA, Balaji S, Beach CM, Benjamin MN, et al. 2021 PACES Expert Consensus Statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). JACC Clin Electrophysiol 2021;7(11):1437–1472.
- PACES/HRS Expert Consensus Statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).Heart Rhythm. 2014; 11: e102-e165
- Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial.Lancet. 2014; 384: 583-590
- Greater mortality risk among patients with delayed follow-up after implantable cardioverter defibrillator procedures.Can J Cardiol. 2014; 30: 598-605
- A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial.Eur Heart J. 2012; 34: 605-614
- Role of automatic wireless remote monitoring immediately following icd implant: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) Trial.J Cardiovasc Electrophysiol. 2016; 27: 321-326
- The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts.J Am Coll Cardiol. 2011; 57: 1181-1189
- Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE).Eur Heart J. 2019; 40: 1837-1846
- Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.Circulation. 2010; 122: 325-332
- A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial).Eur Heart J. 2011; 33: 1105-1111
- Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.Europace. 2009; 11: 483-488
- Automatic home monitoring of implantable cardioverter defibrillators.Europace. 2008; 10: 729-735
- Long-term outcome after ICD and CRT implantation and influence of remote device follow-up.Circulation. 2010; 122: 2359-2367
- Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial.Eur J Heart Fail. 2017; 19: 416-425
- Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators.Circulation. 2012; 125: 2985-2992
- Remote device interrogation kiosks (ReDInK) - pharmacy kiosk remote testing of pacemakers and implantable cardioverter-defibrillators for rural Victorians. A novel strategy to tackle COVID-19.Heart Lung Circ. 2021; 30: 1044-1049
- The use of app-based follow-up of cardiac implantable electronic devices.Card Fail Rev. 2020; 6 (e03–03)
- Real-world adoption of smartphone-based remote monitoring using the Confirm RxTM Insertable Cardiac Monitor.J Innov Card Rhythm Manag. 2021; 12: 4613-4620
- Implantable cardiac electronic devices in the elderly population.Arrhythm Electrophysiol Rev. 2019; 8: 143-146
- The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients.J Am Coll Cardiol. 2015; 65: 2601-2610
- Pacing and defibrillators in complex congenital heart disease.Arrhythm Electrophysiol Rev. 2016; 5: 57-64
- Multi-institutional study of implantable defibrillator lead performance in children and young adults.Circulation. 2013; 127: 2393-2402
- New RANZCR clinical radiology written report guidelines.J Med Imaging Radiat Oncol. 2019; 63: 7-14
- MRI safety management in patients with cardiac implantable electronic devices: utilizing failure mode and effects analysis for risk optimization.Int J Qual Health Care. 2020; 32: 431-437
- Utilization and programming of an automatic MRI recognition feature for cardiac rhythm management devices.Heart Rhythm O2. 2021; 2: 132-137
- Assessing the risks associated with MRI in patients with a pacemaker or defibrillator.N Engl J Med. 2017; 376: 755-764
- Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures.Heart Rhythm. 2010; 7: 1048-1055
- Contributions of remote monitoring to the follow-up of implantable cardioverter–defibrillator leads under advisory.Eur Heart J. 2010; 31: 2246-2252
Article info
Publication history
Published online: June 24, 2022
Accepted:
May 5,
2022
Received:
April 19,
2022
Identification
Copyright
© 2022 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.
